NCT05578534

Brief Summary

Background The arteriovenous difference of partial pressure of carbon dioxide (PCO2) between mixed or central venous blood and arterial blood is the ∆PCO2 or CO2 gap. Previous data demonstrated a strong relationship between ∆PCO2 and cardiac index (CI) at the very early phase of resuscitation in septic shock. Monitoring the ∆PCO2 from the beginning of the resuscitation may be a useful tool to assess the adequacy of cardiac output (CO) in tissue perfusion. Aim of work: To examine behavior of ∆PCO2 during early management of septic shock. Methodology: Seventy-six patients with diagnosis of septic shock admitted to critical care department, Cairo university hospitals. We classified the study population according to initial resuscitation response, initial CO2 gap, or 28-days mortality. The response vs non-response to initial resuscitation, ICU morbidity and recovery rate were the study primary outcomes while secondary outcomes included ICU length of stay (LOS) and 28-day ICU Mortality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

October 5, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 13, 2022

Completed
Last Updated

October 13, 2022

Status Verified

October 1, 2022

Enrollment Period

1.8 years

First QC Date

October 5, 2022

Last Update Submit

October 10, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • The response to initial resuscitation

    response to intial resuscitation with IV fluids and vasopressors measured by PCO2 gap

    6 hours

Secondary Outcomes (1)

  • ICU length of stay (LOS) and 28-day mortality

    28 days

Study Arms (6)

High CO2 gap (Pcv-aCO2 > 6 mmHg)

Patients had high PCO2 gaps before initial resuscitation

Normal CO2 gap (Pcv-aCO2 ≤6 mmHg)

Patients had normal PCO2 gaps before initial resuscitation

Responsive (15% increase in CI or stable MAP was achieved)

Patients who respond to initial resuscitation with 15% increase in CI

Non-responsive (< 15% increase in CI or a stable MAP was not achieved)

Patients who do not respond to initial resuscitation with less than 15% increase in CI

Survivors

Patients who survived after 28 days

Non survivors

Patients who do not survive within 28 days

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

76 consecutive adult patients admitted to critical care department of Cairo university hospitals with septic shock

You may qualify if:

  • adult patients admitted to critical care department of Cairo university hospitals with septic shock and elevated blood lactate level \> 2 mmol/ L requiring fluid resuscitation and/ or vasopressor drugs infusion.

You may not qualify if:

  • Patients with advanced cardiac, pulmonary, hepatic, or renal diseases were excluded from enrolment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Critical care department

Cairo, 12358, Egypt

Location

MeSH Terms

Conditions

Shock, Septic

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • Farouk Faris, MD

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
28 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of critical care

Study Record Dates

First Submitted

October 5, 2022

First Posted

October 13, 2022

Study Start

December 1, 2020

Primary Completion

September 30, 2022

Study Completion

October 1, 2022

Last Updated

October 13, 2022

Record last verified: 2022-10

Locations